Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 2 , Pages 97-104, Summer 2009

Current Status of Screening for Malignant Pleural Mesothelioma

  • Harvey I. Pass, MD

      Affiliations

    • Division of Thoracic Surgery and Thoracic Oncology, Department of Cardiothoracic Surgery, NYU Langone Medical Center, New York, New York
    • Corresponding Author InformationAddress reprint requests to Harvey I. Pass, MD, Division of Thoracic Surgery and Thoracic Oncology, Department of Cardiothoracic Surgery, NYU Langone Medical Center, 530 First Avenue, Suite 9V, New York, NY 10016
    • ,
  • Michele Carbone, MD, PhD

      Affiliations

    • Department of Pathology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Pass has a patent application for the use of osteopontin in asbestos-related malignancies.

PII: S1043-0679(09)00071-9

doi:10.1053/j.semtcvs.2009.06.007

Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 2 , Pages 97-104, Summer 2009

Article Tools